Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung [Phase 2]
This document reports the completion status of a Phase II trial evaluating the TX regimen as first-line treatment for Asian elderly patients…
-
CLINICAL_TRIALS research · 2012-02-24Clinical Trial Update: Tarceva Italian Lung Optimization tRial [Phase 3]
A Phase 3 clinical trial of Tarceva (erlotinib) for non-small cell lung cancer conducted in Italy is listed with an unknown status.
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. [Phase 1]
This document reports the results of a Phase 1 bioequivalence study of Vinorelbine tartrate injectable emulsion in patients with advanced ca…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer [Phase 1]
Phase I trial of DOTAP-based liposome delivering Cholesterol-Fus1 in non-small cell lung cancer has completed.
-
FDA approval · 2012-02-17FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental NDA (NDA 202570) for XALKORI (crizotinib) from Pfizer Laboratories Div Pfizer Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating the combination of pazopanib and pemetrexed in advanced non-small cell lung cancer; results were posted in F…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) [Phase 2]
This update reports the completion of a Phase 2 trial evaluating the efficacy of an investigational drug in adults with non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial of pioglitazone in adults undergoing surgery for non-small cell lung cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors
A feasibility study comparing performance status with objective physical activity monitors in Non-Small Cell Lung Cancer has been terminated…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer [Phase 2]
This Phase 2 trial of apatinib in patients with advanced non-squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2012-02-08Clinical Trial Update: Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A Phase I/II clinical trial for patients with recurrent or refractory non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2012-02-07Clinical Trial Update: Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Paclitaxel plus Carboplatin with or without M2ES in non-small cell lung cancer; the status is not dis…
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors [Phase 1]
This document reports the completion of a Phase 1 safety study evaluating XL765 (SAR245409) in combination with erlotinib in adults with sol…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy [Phase 2]
Phase II study of E7389 (eribulin, Halaven), a halichondrin B analogue, in patients with advanced non-small cell lung cancer who progressed …
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and gemcitabine with bevacizumab every 2 weeks for stage IIIb/IV non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Completed Phase 1/2 safety study evaluating MKC-1 in combination with pemetrexed for advanced cancer and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.
A completed study in non-small cell lung cancer in Antwerp evaluated whether timely analysis of EGFR mutation status is feasible in the regi…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluating the combination of imatinib mesylate and docetaxel in non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS research · 2012-01-11Clinical Trial Update: Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
This is a tissue collection study involving patients with resectable non-small cell lung cancer; the document provides no results or status …
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This clinical trial update describes results from a Phase 1/2 study evaluating OGX-011 in combination with gemcitabine and a platinum-based …
-
CLINICAL_TRIALS research · 2012-01-04Clinical Trial Update: Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This is a Phase 2 clinical trial update evaluating cisplatin/etoposide with concurrent radiotherapy, with or without celecoxib, in unresecta…
-
CLINICAL_TRIALS research · 2011-12-29Clinical Trial Update: Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC)
This clinical trial evaluated whole-body MRI combined with PET for staging non-small cell lung cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing two chemotherapy regimens in advanced non-squamous non-small cell lung cancer; results have been posted.
-
CLINICAL_TRIALS research · 2011-12-23Clinical Trial Update: Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations [Phase 2]
Clinical trial comparing the EGFR inhibitor erlotinib against vinorelbine/cisplatin as adjuvant therapy for stage IIIA non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment [Phase 2]
Phase II trial evaluating the combination of docetaxel and oxaliplatin as second-line therapy in advanced non-small cell lung cancer, includ…